Skip to content

Clinical trials

Respiratory Distress Syndrome trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20081
20121
20191
20201
20211
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aqualung Therapeutics Corp.1
AstraZeneca1
Australian and New Zealand Intensive Care Research Centre1
Bayside Health1
Cynata Therapeutics Limited1
Eli Lilly and Company1
Peninsula Health1
Pneuma Pharmaceuticals Incorporated1
Royal Hospital For Women1
University of Michigan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome12
COVID-192
Acute Lung Injury1
Coronavirus Infections1
Drowning1
Infections1
Influenza, Human1
Lung Diseases1
Pneumonia1
Premature Birth1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.